Special Notices

The West Virginia Clinical and Translational Institute is accepting Pilot Project Funding applications for clinical and translational research (T1-T4). Translational research specifically aims at utilizing new discoveries and best practices to improve the lives of people in our community, focusing on West Virginia and Appalachia at large. Please note the following phases of translational research:

• Phase One (T1) research seeks to move a basic discovery into a candidate’s health application.

• Phase Two (T2) research assesses the value of T1 application for health practice leading to the development of evidence-based guidelines.

• Phase Three (T3) research attempts to move evidence-based guidelines into health practice through delivery, dissemination, and diffusion research.

• Phase Four (T4) research seeks to evaluate the “real world” health outcomes of a T1 application in practice.
  
  

The purpose of this funding mechanism is to provide an opportunity and resources to support innovative, collaborative research relevant to health challenges and disparities in West Virginia. Pilot funding is being disbursed through the WV IDeA-CTR NIH/NIGMS Award Number U54GM104942 in partnership with other WVCTSI member institutions (WVU, WVU-C/CAMC Institute, and WVSOM).

For more details and full funding announcement, see: http://www.wvctsi.org/pages/Programs/Clinical-Translational-Pilot-Grants-Program/Pilot-Funding-for-Clinical-and-Translational-Proje

Information: Abigail Miller, phone: 304-581-1957; fax: 304-293-9074; amille50@hsc.wvu.edu.